Action 002198 GUANGDONG JIAYING PHARMACEUTICAL CO., LTD
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Guangdong Jiaying Pharmaceutical Co., Ltd

Actions

002198

CNE1000008P1

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 22/05/2024 		Varia. 5j. Varia. 1 janv.
6,77 CNY -2,03 % Graphique intraday de Guangdong Jiaying Pharmaceutical Co., Ltd +9,72 % -7,01 %
26/04 Guangdong Jiaying Pharmaceutical Co. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
26/04 Guangdong Jiaying Pharmaceutical Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Announcement of Resolutions of Guangdong Jiaying?s Fifth Extraordinary General Meeting of Shareholders in 2021
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Guangdong Jiaying Pharmaceutical Co., Ltd. Approves Management Appointments
Resolutions on Supervisor Nomination by Guangdong Jiaying Venture Capital
Guangdong Jiaying Venture Capital Submits Proposals Related to Supervisor Nominations
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Guangzhou Taiping Enterprise Management Partnership (Limited Partnership) signed the Share Transfer Agreement to acquire 5% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Shaobin for approximately CNY 195 million.
Jiaying Pharma Sees Up to 3,420% Surge in 2022 Profit
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
Jiaying Pharmaceutical’s Profit Crashes 93% in 2021 Despite Revenue Growth
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
Liu Libiao completed the acquisition of 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Huang Zhiyong and Huang Libing.
Chen Shaobin completed the acquisition of 10% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Yonghong.
Liu Libiao agreed to acquire 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Huang Zhiyong and Huang Libing for approximately CNY 210 million.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 002198
  4. Actualités Guangdong Jiaying Pharmaceutical Co., Ltd
  5. Autres langues
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT